During the past decade, Medical Co. LTA Sumida Hospital conducted 3 clinical trials. In the 10-year time frame, 3 clinical trials started and 0 clinical trials were completed, i.e. on average, 0% percent of trials that started reached the finish line to date. In the past 5 years, 3 clinical trials started and 0 clinical trials were completed. i.e. 0% of trials that started reached the finish line.

According to Clinical.Site data, the most researched conditions in "Medical Co. LTA Sumida Hospital" are "Parkinson's Disease" (2 trials), "Cutaneous Lupus Erythematosus (CLE)" (1 trials), "Healthy Volunteers" (1 trials), "Pneumococcal Conjugate Vaccine" (1 trials) and "Pneumococcal Vaccines" (1 trials). Many other conditions were trialed in "Medical Co. LTA Sumida Hospital" in a lesser frequency.

Most popular intervention types in "Medical Co. LTA Sumida Hospital" are "Drug" (3 trials) and "Biological" (1 trials). Other intervention types were less common.

The name of intervention was led by "KW-6356" (2 trials), "Placebo" (2 trials), "13-valent pneumococcal conjugate vaccine" (1 trials), "23-valent pneumococcal polysaccharide vaccine" (1 trials) and "Clarithromycin" (1 trials). Other intervention names were less common.

The vast majority of trials in "Medical Co. LTA Sumida Hospital" are 3 trials for "All" genders and 1 trials for "Male" genders.

Currently, there are NaN active trials in "Medical Co. LTA Sumida Hospital". 1 are not yet recruiting, undefined are recruiting, undefined are Active, not recruiting, and undefined are Enrolling by invitation. In total, there were 3 completed trials in Medical Co. LTA Sumida Hospital, undefined suspended trials, and undefined terminated clinical trials to date.

Out of the total trials that were conducted in Medical Co. LTA Sumida Hospital, 3 "Phase 1" clinical trials were conducted, 0 "Phase 2" clinical trials and 1 "Phase 3" clinical trials were conducted as well. "Phase 4" trials included 0 trials, and there were also 0 trials that are defined as “Not Applicable".